ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

kedrion s.p.a. - hepatitis b immunglobulin, humant - injektionsvæske, opløsning - 180 ie/ml

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - hepatitis b immunglobulin, humant - injektionsvæske, opløsning - 180 ie/ml

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

novartis europharm limited - eltrombopag - purpura, trombocytopenisk, idiopatisk - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 og 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 og 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

prothya biosolutions netherlands b.v. - normalt immunglobulin, humant - infusionsvæske, opløsning - 50 mg/ml

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombocytopeni - antihemorrhagics - doptelet er indiceret til behandling af svær trombocytopeni hos voksne patienter med kronisk leversygdom, der er planlagt til at blive en invasiv procedure. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. kortikosteroider, immunglobuliner).

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

laboratoire francais du fractionnement et des biotechnologies - normalt immunoglobulin til intravenøs brug, humant - infusionsvæske, opløsning - 100 mg/ml

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

octapharma ab - normalt immunglobulin, humant - infusionsvæske, opløsning - 50 mg/ml

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

csl behring gmbh - anti-d immunglobulin, humant - injektionsvæske, opløsning i fyldt injektionssprøjte - 200 mikrogram

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - hepatitis b immunglobulin, humant - injektionsvæske, opløsning - 180 ie/ml

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrémidler, tarm antiinflammatorisk / antiinfective agenter - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.